Enzyme/Prodrug Gene Therapy: Comparison of Cytosine Deaminase/5-Fluorocytosine Versus Thymidine Kinase/Ganciclovir Enzyme/Prodrug Systems in a Human Colorectal Carcinoma Cell Line

Cancer Research

Volumn 55, Issue 21, 1995, Pages 4808-4812

  Trinh, Quynh T ^a   Austin, Elizabeth A ^a   Murray, Doris M ^a   Knick, Vincent C ^a   Huber, Brian E ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE DEAMINASE; FLUCYTOSINE; GANCICLOVIR; THYMIDINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CELL JUNCTION; COLORECTAL CARCINOMA; CYTOTOXICITY; DESMOSOME; GENE EXPRESSION; GENE THERAPY; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; LIVER METASTASIS; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY;

ANIMAL; ANTIMETABOLITES, ANTINEOPLASTIC; BASE SEQUENCE; COLORECTAL NEOPLASMS; COMPARATIVE STUDY; DRUG SCREENING ASSAYS, ANTITUMOR; FLUCYTOSINE; GANCICLOVIR; GENE THERAPY; HUMAN; MICE; MICE, NUDE; MICROSCOPY, ELECTRON; MOLECULAR SEQUENCE DATA; NEOPLASM TRANSPLANTATION; NUCLEOSIDE DEAMINASES; PRODRUGS; SIMPLEXVIRUS; THYMIDINE KINASE; TUMOR CELLS, CULTURED;

EID: 0028800141     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Kemeny, N. Current approaches to metastatic colorectal cancer. Semin. Oncol., 21: 67–75, 1994.
2. Kemeny, N., Lokich, J. J., Anderson, N., and Ahlgren, J. D. Recent advances in the treatment of advanced colorectal cancer. Cancer (Phila.), 71: 9–18, 1993.
3. Abbruzzese, J. L., and Levin, B. Treatment of advanced colorectal cancer. Hemat. Oncol. Clin. N. Am., 3: 135–153, 1989.
4. Cortesi, E., Padovani, A., Aloe, A., Picece, V., Pellegrini, P., and Pellegrini, A. Advanced colorectal cancer: impact of chemotherapy on survival. J. Surg. Oncol., 2 (Suppl.): 112–115, 1991.
5. Hunt, T. M., and Taylor, I. The role of chemotherapy in the treatment and prophylaxis of colorectal liver metastases. Cancer Surv., 8: 71–90, 1989.
6. Gunderson, L. L., Beart, R. W., and O'Connell, M. J. Current issues in the treatment of colorectal cancer. CRC Crit. Rev. Oncol. Hematol., 6: 223–260, 1986.
7. Huber, B. E., Richards, C. A., and Krenistsky, T. A. Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: an innovative approach for cancer therapy. Proc. Natl. Acad. Sci. USA, 88: 8039–8043, 1991.
8. Austin, E. A., and Huber, B. E. A first step in the development of gene therapy for colorectal carcinoma: cloning, sequencing, and expression of E. coli cytosine deaminase. Mol. Pharmacol., 43: 380–387, 1993.
9. Huber, B. E., Austin, E. A., Good, S. S., Knick, V. C., Tibbels, T., and Richards, C. A. In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase. Cancer Res., 53:4619–4626,1993.
10. Huber, B. E., Austin, E. A., Richards, C. A., Davis, S. T., and Good, S. S. Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase. Proc. Natl. Acad. Sci. USA, 91: 8302–8306, 1994.
11. Huber, B. E., Richards, C. A., and Austin, E. A. Virus-directed enzyme/prodrug therapy (VDEPT) selectively engineering drug sensitivity into tumors. In: B. E. Huber and J. S. Lazo (eds.), Gene Therapy for Neoplastic Diseases, pp. 104–114. New York: New York Academy of Sciences, 1994.
12. Richards, C. A., Austin, E. A., and Huber, B. E. Transcriptional regulatory sequences of carcinoembryonic antigen: identification and use with cytosine deaminase for tumor-specific gene therapy. Hum. Gene Ther., 6: 881–893, 1995.
13. Domin, B. A., Mahony, W. B., and Zimmerman, T. P. Transport of 5-fluorouracil and uracil into human erythrocytes. Biochem. Pharmacol., 46: 503–510, 1993.
14. Bi, W. L., Parysek, L. M., Warnick, R., and Stambrook, P. J. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSVtk retroviral gene therapy. Hum. Gene Ther., 4: 725–731, 1993.
15. Barba, D., Hardin, J., Sadelain, M., and Gage, F. H. Development of antitumor immunity following thymidine kinase-mediated killing of experimental brain tumors. Proc. Natl. Acad. Sci. USA, 91: 4348–4352, 1994.
16. Caruso, M., Panis, Y., Gagandeep, S., Houssin, D., Salzmann, J. L., and Klatzmann, D. Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. Proc. Natl. Acad. Sci. USA, 90: 7024–7028, 1993.
17. Takamiya, Y., Short, M. P., Ezzedine, Z. D., Moolten, F. L., Breakefield, X. O., and Martuza, R. L. Gene therapy of malignant brain tumors: a rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells. J. Neurosci. Res., 33: 493–503, 1992.
18. Moolten, F. L., and Wells, J. M. Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. J. Natl. Cancer Inst., 82: 297–300, 1990.
19. Moolten, F. L., Wells, J. M., Heyman, R. A., and Evans, R. M. Lymphoma regression induced by ganciclovir in mice bearing a herpes thymidine kinase transgene. Hum. Gene Ther., 1: 125–134, 1990.
20. Manome, Y., Abe, M., Hagen, M. F., Fine, H. A., and Kufe, D. W. Enhancer sequences of the DF3 gene regulate expression of the herpes simplex virus thymidine kinase gene and confer sensitivity of human breast cancer cells to ganciclovir. Cancer Res., 54: 5408–5413, 1994.
21. Culver, K. W., Ram, Z., Wallbridge, S., Ishij, H., Oldfield, E. H., and Blaese, R. M. In vivo gene transfer with retroviral-producer cells for treatment of experimental brain tumors. Science (Washington DC), 256: 1550–1552, 1992.
22. Committee on the Care and Use of Laboratory Animals. Guide for the Care and Use of Laboratory Animals, NIH Publication No. 86–23. Washington, DC: U.S. Department of Health and Human Services, 1985.
23. Franke, W. W., Troyanovsky, S. M., Koch, P. J., Troyanovsky, R., Fouquet, B., and Leube, R. E. Desmosomal proteins: mediators of intercellular coupling and intermediate filament anchorage. In: Cold Spring Harbor Symposia on Quantitative Biology, Volume LVII, pp. 643–652. Plainview, NY: Cold Spring Harbor Laboratory, 1992.
24. Bruno, M. C., Benedetti, S., Ottolenghi, S., Mora, M., Polio, B., Poli, G., and Finocchiaro, G. The bystander effect: association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice. Hum. Gene Ther., 6: 763–772, 1995.